Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004139
What this trial is testing

Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 80
Large-scale testing (Phase 3)UnknownNCT02859077
What this trial is testing

EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism

Who this might be right for
Non-Small-Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 100
Not applicableStudy completedNCT00899028
What this trial is testing

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

Who this might be right for
Lung Cancer
Vanderbilt University Medical Center 689
Testing effectiveness (Phase 2)Study completedNCT01181401
What this trial is testing

InductionChemo-Radio-Antibody-Treatment

Who this might be right for
Squamous Cell Carcinoma of the HeadSquamous Cell Carcinoma of the Neck
Charite University, Berlin, Germany 94
Early research (Phase 1)WithdrawnNCT02451865
What this trial is testing

Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07634601
What this trial is testing

Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaRecurrent Endometrial Carcinoma+2 more
Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00697619
What this trial is testing

To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Looking for participantsNCT04090567
What this trial is testing

Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer

Who this might be right for
Advanced Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+12 more
M.D. Anderson Cancer Center 60
Early research (Phase 1)Study completedNCT00058253
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Recurrent Prostate CancerStage IV Prostate CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00664781
What this trial is testing

Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more
Cancer Research UK 78
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT07104630
What this trial is testing

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

Who this might be right for
Non-small Cell Lung Cancer Stage IIINon-small Cell Lung Cancer Stage IVNon-small Cell Lung Cancer+1 more
Case Comprehensive Cancer Center 85
Testing effectiveness (Phase 2)Study completedNCT00182767
What this trial is testing

Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer

Who this might be right for
Fallopian Tube CancerFemale Reproductive CancerRecurrent Breast Cancer+4 more
National Cancer Institute (NCI) 45
Early research (Phase 1)Study completedNCT00002828
What this trial is testing

Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00049660
What this trial is testing

Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 47
Testing effectiveness (Phase 2)Study completedNCT00262886
What this trial is testing

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of Rochester 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT02797470
What this trial is testing

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

Who this might be right for
HIV InfectionMature T-Cell and NK-Cell Non-Hodgkin LymphomaPlasmablastic Lymphoma+8 more
AIDS Malignancy Consortium 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT02411656
What this trial is testing

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

Who this might be right for
EdemaErythemaEstrogen Receptor Negative+6 more
M.D. Anderson Cancer Center 71
Post-approval studies (Phase 4)Looking for participantsNCT07357597
What this trial is testing

An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.

Who this might be right for
Stomatitis
AstraZeneca 100
Large-scale testing (Phase 3)Study completedNCT00293462
What this trial is testing

GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerMucositis OralRadiation Toxicity+1 more
Marilyn Dodd 91
Next Page